Lataa...
Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiency
Postmenopausal women are at increased risk of osteoporosis. Osteoporotic fractures carry an increased risk of morbidity and mortality. Denosumab is a monoclonal antibody widely used for the treatment of osteoporosis by inhibiting osteoclast-induced bone resorption. Hypocalcaemia is a known side-effe...
Tallennettuna:
| Julkaisussa: | BMJ Case Rep |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7451275/ https://ncbi.nlm.nih.gov/pubmed/32847872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-234508 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|